Induction Chemotherapy Sequential Sintilimab Combined With Dual Epigenetic Drugs for ENKTL-HLH
Clinical trial NCT05008666 · UNKNOWN
Trial details
- NCT number
- NCT05008666
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2022-11-30
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.